Annals of Family Medicine

NOVEMBER 20, 2024

Context: Diabetic retinopathy (DR) is the most common complication of diabetes mellitus and is the leading cause of blindness in working age Americans. Outcomes were reported as odds ratios (OR) with 95% confidence intervals (CI).

Diabetes 130

Diabetes Screening Insurance Healthcare 130

FDA Law Blog

MAY 17, 2022

But in May 2019, FDA approved a second amifampridine drug product, Jacobus Pharmaceutical Company, Inc.’s But even before the House Energy and Commerce Committee acts, the Senate Health, Education, Labor and Pensions Committee held a April 26, 2022 hearing on UFA reauthorization. and more likely 15-20. and Peter Marks, M.D.,

IT 40

IT Patients Provider Individual 40

FDA Law Blog

JULY 10, 2023

Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 These AI requests often address complicated scientific scenarios in which a submitter has already provided some information, but FDA is not completely satisfied. Average Number of Industry Days to MDUFA IV Decision 54.69

Provider 75

Provider IT Engineering Medical 75

The Clinical Problem Solvers

APRIL 5, 2022

Dr. Kushel detailed how the use of dehumanizing language equates to complicity in a narrative that systemically harms our neighbors with lived expertise in homelessness. Published April 5, 2019. January 18, 2019. link] Homeless community in San Diego resists police terror and demands safe housing – Liberation News Lopez, M.,

Community 52

Community Patient-Centered Emergency Room Medical 52

The Clinical Problem Solvers

FEBRUARY 8, 2023

Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. One example that is presented involves the complicated relationship between the United States and Chinese immigrants and farmworkers in California. Published September 2019. Arnaout, B.,

Community 52

Community Patient-Centered Mental Health Board-Certified 52

GeriPal

MARCH 9, 2023

In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Alex: It’s complicated. We, for very complicated reasons, ended up with niacin. And yet there are reasons for caution. So, creating a- Alex: Control condition. Eric: Yeah.

Patient-Centered 91

Patient-Centered Community IT Medical 91